The summary below is from the full report titled “Meta-Analysis: Effect of Long-Acting β-Agonists on Severe Asthma Exacerbations and Asthma-Related Deaths.” It is in the 20 June 2006 issue of Annals of Internal Medicine (volume 144, pages 904-912). The authors are S.R. Salpeter, N.S. Buckley, T.M. Ormiston, and E.E. Salpeter.
What Are the Risks of Using Inhaled Long-Acting Beta-Agonist Medications for the Relief of Asthma?. Ann Intern Med. 2006;144:I–30. doi: https://doi.org/10.7326/0003-4819-144-12-200606200-00002
Download citation file:
Published: Ann Intern Med. 2006;144(12):I-30.
Asthma, Pulmonary/Critical Care.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use